Breast Cancer in the LGBTQIA+ Population
DOI:
https://doi.org/10.32635/2176-9745.RBC.2023v69n4.4511Keywords:
breast neoplasms, sexual and gender minorities, disease preventionAbstract
Breast cancer is a global public health concern affecting millions of individuals every year, but it can be quite singular for the LGBTQIA+ population who deals with unique health challenges. Due to its relevance and paucity of studies on breast cancer for this population, this opinion article aims to emphasize the importance of an inclusive approach for breast cancer treatment and prevention, addressing existing disparities and suggesting consistent strategies to promote health equity, as health inequities, specific risk factors, psychosocial challenges, awareness and education campaigns and inclusion in clinical trials.
Downloads
References
Instituto Nacional de Câncer. Estimativa 2023: incidência do câncer no Brasil [Internet]. Rio de Janeiro: INCA; 2022. [acesso 2023 nov 30]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2023.pdf
Oliveira DAL. Políticas de saúde e diagnóstico precoce do câncer de mama no Brasil. Rev Enferm Digit Cuid Promoção da Saúde, 2019;4(1):46-50. doi: https://doi.org/10.5935/2446-5682.20190009 DOI: https://doi.org/10.5935/2446-5682.20190009
Howlader N, Noone AM, Krapcho M, et al, organizadores. SEER cancer statistics review, 1975-2018. Bethesda: Nacional Cancer Institute; 2018. [acesso 2023 nov 30]. Disponível em: https://seer.cancer.gov/archive/csr/1975_2018/index.html
Migowski A, Silva GA, Dias MBK, et al. Diretrizes para detecção precoce do câncer de mama no Brasil. II – Novas recomendações nacionais, principais evidências e controvérsias. Cad. Saúde Pública. 2018;34(6):e00074817. doi: https://doi.org/10.1590/0102-311X00074817https://doi.org/10.1590/0102-311X00074817 DOI: https://doi.org/10.1590/0102-311x00074817
International Agency for Research on Cancer. Breast cancer screening [Internet]. v. 15. Lion: IARC; 2016. [acesso 2023 nov 30]. Disponível em: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Handbooks-Of-Cancer-Prevention/Breast-Cancer-Screening-2016
Hasset MJ, Somerfield MR, Baker ER, et. al. Management of Male Breast Cancer. Am Soc Clin Oncol. 2020;38(6):1849-63. Disponível em: https://ascopubs.org/doi/full/10.1200/JCO.19.03120 DOI: https://doi.org/10.1200/JCO.19.03120
Gibson AW, Radix AE, Maingi S, et al. Cancer care in lesbian, gay, bisexual, transgender and queer populations. Future Oncol. 2017;13(15):1333-44. DOI: https://doi.org/10.2217/fon-2017-0482
Puechl AM, Russel K, Gray BA. Care and cancer screening of the transgender population. J Womens Health 2019; 28(6):761-768. DOI: https://doi.org/10.1089/jwh.2018.6945
Stone JP, Hartley RL. Temple-Oberle C. Breast cancer in transgender patients: A systematic review. Part 2: Female to Male. Eur J Surg Oncol. 2018;44(10):1463-8. doi: https://doi.org/10.1016/j.ejso.2018.06.021 DOI: https://doi.org/10.1016/j.ejso.2018.06.021
Hartley RL, Stone JP, Temple-Oberle C. Breast cancer in transgender patients: A systematic review. part 1: male to female. Eur J Surg Oncol. 2018;44(10):1455-62. doi: https://doi.org/10.1016/j.ejso.2018.06.035 DOI: https://doi.org/10.1016/j.ejso.2018.06.035
Spizzirri G, Eufrásio R, Lima MCP, et al. Proporção de pessoas identificadas como transexuais e não binárias no Brasil. Sci Rep. 2021;11(1):2240. doi: https://doi.org/10.1038/s41598-021-81411-4 DOI: https://doi.org/10.1038/s41598-021-81411-4
Barrett J. Gender dysphoria: assessment and management for non-specialists. BMJ. 2017;30:357:j2866. doi: https://doi.org/10.1136/bmj.j2866 DOI: https://doi.org/10.1136/bmj.j2866
Sant’Ana RSE. Strategies for inclusive care to LGBTQIAP+ people with cancer. Rev Bras Cancerol. 2023;69(2):e-163671. DOI: https://doi.org/10.32635/2176-9745.RBC.2023v69n2.3671
Braun H, Nash R, Tangpricha V, et al. Cancer in transgender people: evidence and methodological considerations. Epidemiol Rev. 2017;39(1):93-107. doi: https://doi.org/10.1093/epirev/mxw003 DOI: https://doi.org/10.1093/epirev/mxw003
Price S, McManus J, Barrett J. The transgender population: improving awareness for gynaecologists and their role in the provision of care. The Obstet Gynaecol. 2019;21(1):11-20. doi: https://doi.org/10.1111/tog.12521 DOI: https://doi.org/10.1111/tog.12521
Blok CJ, Wiepjes CM, Nota NM, et. al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the netherlands british medical journal. BMJ. 2019;365:1652. doi: https://doi.org/10.1136/bmj.l1652 DOI: https://doi.org/10.1136/bmj.l1652
Patel H, Arruarana V, Yao L, et al. Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review. Endocrine. 2020;68(1):6-15. DOI: https://doi.org/10.1007/s12020-020-02197-5
Domene FM, Silva JL, Toma TS, et al. Saúde da população LGBTQIA+: revisão de escopo rápida da produção científica brasileira. Ciênc saúde coletiva. 2022; 27(10):3835-48. DOI: https://doi.org/10.1590/1413-812320222710.07122022en
Charkhchi P, Schabath MB, Carlos RC. Modifiers of cancer screening prevention among sexual and gender minorities in the behavioral risk factor surveillance system. J Am Coll Radiol; 2019;16(4PtB):607-20. doi: https://doi.org/10.1016/j.jacr.2019.02.042 DOI: https://doi.org/10.1016/j.jacr.2019.02.042
Chapman-Pratt ML, Ward AR. Provider recommendations are associated with cancer screening of transgender and gender-nonconforming people: a cross-sectional urban survery. Transgend Health; 2020;5(2):80-5. doi: Disponível em: https://doi.org/10.1089/trgh.2019.0083 DOI: https://doi.org/10.1089/trgh.2019.0083
Bazzi AR, Whorms DS, King DS, et al. Adherence to mammography screening guidelines among transgender persons and sexual minority women. Am J Public Health. 2015;105(11):2356-8. DOI: https://doi.org/10.2105/AJPH.2015.302851
Deutsch MB, Radix A, Wesp L. Breast cancer screening, management, and a review of case study literature in transgender populations. Semin Reprod Med. 2017;35(5):434-41. doi: https://doi.org/10.1055/s-0037-1606103 DOI: https://doi.org/10.1055/s-0037-1606103
Calas MJG, Dantas RFA, Ciscotto CB, et al. Integrative review on breast cancer screening in the transgender population: what do we know? Mastology 2022;32:e20210051. doi: https://doi.org/10.29289/2594539420210051 DOI: https://doi.org/10.29289/2594539420210051
Corso G, Gandini S, D'Ecclesiis O, et al. Risk and incidence of breast cancer in transgender individuals: a systematic review and meta-analysis. Eur J Cancer Prev. 2023;32(3):207-14. DOI: https://doi.org/10.1097/CEJ.0000000000000784
Nikolić D, Granić M, Ivanović N, et al. Breast cancer and its impact in male transsexuals. Breast Cancer Res Treat. 2018;171(3):565-9. doi:
https://doi.org/10.1007/s10549-018-4875-y DOI: https://doi.org/10.1007/s10549-018-4875-y
Stewart T, Lee YA, Damiano EA. Do transgender and gender diverse individuals receive adequate gynecologic care? an analysis of a rural academic center. Transgend Health. 2020;5(1):50-8. doi: https://doi.org/10.1089/trgh.2019.0037 DOI: https://doi.org/10.1089/trgh.2019.0037
Labanca T, Mañero I, Pannunzio M. Transgender patients: considerations for routine gynecologic care and cancer screening. Inter J Gynec Cancer. 2020;30(12):1990-6. doi: https://doi.org/10.1136/ijgc-2020-001860 DOI: https://doi.org/10.1136/ijgc-2020-001860
Mendonça WJR. Breast cancer screening in transgenders: an integrative literature review. Res Soc Devel. 2022;11(17):e245111738953. doi: https://doi.org/10.33448/rsd-v11i17.38953 DOI: https://doi.org/10.33448/rsd-v11i17.38953
Schmidt E, Rizzolo D. Disease screening and prevention for transgender and gender-diverse adults. JAAPA. 2017;30(10):11-6. doi: https://doi.org/10.1097/01.JAA.0000524709.87224.57 DOI: https://doi.org/10.1097/01.JAA.0000524709.87224.57
Narayan A, Lebron-Zapata L, Morris E. Breast cancer screening in transgender patients: findings from the 2014 BRFSS survey. Breast Cancer Res Treat. 2017;166(3):875-9. doi: https://doi.org/10.1007/s10549-017-4461-8 DOI: https://doi.org/10.1007/s10549-017-4461-8
Fredriksen-Goldsen KI. The aging and health report: disparities and resilience among lesbian, gay, bisexual, and transgender older adults. Public Policy Aging Rep. 2011;21(3):3-7. DOI: https://doi.org/10.1093/ppar/21.3.3
Eismann J, Heng YJ, Fleischmann-Rose K, et al. Interdisciplinary management of transgender individuals at risk for breast cancer: case reports and review of the literature. Clinical Breast Cancer. 2019;19(1):e-12-9. doi: https://doi.org/10.1016/j.clbc.2018.11.007 DOI: https://doi.org/10.1016/j.clbc.2018.11.007
Kiran T, Davie S, Singh D, et.al. Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data. Can Fam Physician. 2019;65(1):e30-7.
Gkiouleka A, Wong G, Sowden Sarah S. el al. Reducing health inequalities through general practice. The Lancet Public Health. 2023;8(8):e583. doi: https://doi.org/10.1016/S2468-2667(23)00093-2 DOI: https://doi.org/10.1016/S2468-2667(23)00093-2
Sterling J, Garcia MM. Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model. Transl Androl Urol. 2020;9(6):2771-85. http://dx.doi.org/10.21037/tau-20-954 DOI: https://doi.org/10.21037/tau-20-954
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
This work is licensed under a Creative Commons Attribution 4.0 International License.
